MDT250103P80000
- 0.01
- 0.000.00%
Medtronic Newsroom
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
RBC Capital Sticks to Its Buy Rating for Medtronic (MDT)
Diabetes Device Maker Beta Bionics Files for $100M IPO
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Fire1 Raises $120M for Breakthrough Heart Failure Management Tech With Investment From Medtronic
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Endologix Announces Leadership Transition
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement With the Medtronic Spinal Division
Medtronic Chairman and CEO Geoff Martha to Speak at J.P. Morgan Healthcare Conference
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
Medtronic Receives CE Mark For Leading Transcatheter Pulmonary Valve Replacement System For Congenital Heart Disease
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
An Intrinsic Calculation For Medtronic Plc (NYSE:MDT) Suggests It's 38% Undervalued
Express News | Medtronic PLC : UBS Cuts Target Price to $85 From $93
Is Medtronic Plc (NYSE:MDT) Among Israel Englander's Top Stock Picks Heading Into 2025?
Wearable Patch Market Report 2025, With Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, IRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry
Is the Robotics Industry Poised for a Surge in 2025? Here Are the Investment Opportunities
Press Releases